Viewing Study NCT04479267


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT04479267
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2020-07-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module